IPO Synopsis
| Syngene International Ltd |
|---|
| Registered Office: Biocon SEZ Biocon Park,Plot No 2 & 3 Bommasandra Inds,Bengaluru-560099, Karnataka |
| Tel. No: 91-80-68915000/67758781 |
| Fax No: 91-80-28083189 |
| Email: investor@syngeneintl.com; Mayank.Verma@syngeneintl |
| Website: www.syngeneintl.com |
| Initial public offer of up to 22,000,000 equity shares of face value of Rs. 10 each ("equity shares") of Syngene International Limited ("company" or "issuer") for cash at a price of Rs. 250 per equity share (including a share premium of Rs. 240 per equity share) ("offer price") through an offer for sale by Biocon Limited (the "selling shareholder") ("offer / offer for sale") aggregating to Rs. 550 crores including a reservation of 2,000,000 equity shares for subscription by Biocon shareholders for cash at a price of Rs. 250 per equity share aggregating up to Rs. 50 crores (the "Biocon shareholders reservation portion"). The offer will constitute 11.0% of the post-offer paid-up equity share capital and the net offer shall constitute 10.0% of the post-offer paid-up equity share capital. Offer Price : Rs. 250 per Equity share of face value of Rs. 10/- each. The offer price is 25 times of the face value. Anchor investor offer price : Rs. 250 per equity share. |
| Issue | Money Payable On | ||
|---|---|---|---|
| Opens On | Closes On | Application | |
| 27-Jul-2015 | 29-Jul-2015 | ₹250.00 - 0.00 | |
| Minimum Application for shares in Nos : 60.0 | Further Multiples of :60.0 |
|---|
| (₹ Cr) | Lead Managers to the Issue | |
|---|---|---|
| Project Cost | 37.00 | Axis Capital Ltd |
| Project Financed through Current Offer | 550.00 | Credit Suisse Securities (India) Pvt Ltd |
| Post Issue Equity Share Capital | 200.00 | Jefferies India Pvt Ltd |
| Issue Price | 250.00 |
| Projects |
|---|
| Listing fees on Stock Exchanges |
| Promoted By |
|---|
| Biocon Ltd |
| Listing At |
|---|
| BSE |
| NSE |
| Registrar To The Issue |
|---|
